rs2407083

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_021098.3(CACNA1H):​c.1668C>T​(p.Pro556Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.128 in 1,546,556 control chromosomes in the GnomAD database, including 13,598 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 982 hom., cov: 34)
Exomes 𝑓: 0.13 ( 12616 hom. )

Consequence

CACNA1H
NM_021098.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -2.57

Publications

4 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 16-1202118-C-T is Benign according to our data. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.57 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.147 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.1668C>T p.Pro556Pro synonymous_variant Exon 9 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.1668C>T p.Pro556Pro synonymous_variant Exon 9 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.1668C>T p.Pro556Pro synonymous_variant Exon 9 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.1668C>T p.Pro556Pro synonymous_variant Exon 9 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.1668C>T p.Pro556Pro synonymous_variant Exon 9 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.1668C>T p.Pro556Pro synonymous_variant Exon 9 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.1668C>T p.Pro556Pro synonymous_variant Exon 9 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.1629C>T p.Pro543Pro synonymous_variant Exon 9 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.1668C>T p.Pro556Pro synonymous_variant Exon 9 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.1629C>T p.Pro543Pro synonymous_variant Exon 9 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.1668C>T p.Pro556Pro synonymous_variant Exon 9 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.1668C>T p.Pro556Pro synonymous_variant Exon 9 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.1668C>T p.Pro556Pro synonymous_variant Exon 9 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.1668C>T p.Pro556Pro synonymous_variant Exon 9 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.1668C>T p.Pro556Pro synonymous_variant Exon 9 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.1668C>T non_coding_transcript_exon_variant Exon 9 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.1668C>T non_coding_transcript_exon_variant Exon 9 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.1668C>T non_coding_transcript_exon_variant Exon 9 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000711442.1 linkn.*1115C>T non_coding_transcript_exon_variant Exon 8 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.1668C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.1668C>T non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.1668C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.1668C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.1668C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.1668C>T non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.1668C>T non_coding_transcript_exon_variant Exon 9 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.1668C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.1668C>T non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518777.1
CACNA1HENST00000711442.1 linkn.*1115C>T 3_prime_UTR_variant Exon 8 of 34 ENSP00000518758.1
CACNA1HENST00000640028.1 linkn.1385+283C>T intron_variant Intron 9 of 34 5 ENSP00000491488.1 A0A1W2PQ19

Frequencies

GnomAD3 genomes
AF:
0.101
AC:
15373
AN:
152178
Hom.:
980
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0376
Gnomad AMI
AF:
0.0749
Gnomad AMR
AF:
0.0847
Gnomad ASJ
AF:
0.0625
Gnomad EAS
AF:
0.0633
Gnomad SAS
AF:
0.156
Gnomad FIN
AF:
0.157
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.136
Gnomad OTH
AF:
0.111
GnomAD2 exomes
AF:
0.115
AC:
16038
AN:
140046
AF XY:
0.121
show subpopulations
Gnomad AFR exome
AF:
0.0348
Gnomad AMR exome
AF:
0.0587
Gnomad ASJ exome
AF:
0.0739
Gnomad EAS exome
AF:
0.0691
Gnomad FIN exome
AF:
0.158
Gnomad NFE exome
AF:
0.135
Gnomad OTH exome
AF:
0.118
GnomAD4 exome
AF:
0.131
AC:
182907
AN:
1394260
Hom.:
12616
Cov.:
36
AF XY:
0.132
AC XY:
91019
AN XY:
687576
show subpopulations
African (AFR)
AF:
0.0335
AC:
1055
AN:
31528
American (AMR)
AF:
0.0619
AC:
2204
AN:
35630
Ashkenazi Jewish (ASJ)
AF:
0.0733
AC:
1840
AN:
25106
East Asian (EAS)
AF:
0.0422
AC:
1505
AN:
35668
South Asian (SAS)
AF:
0.157
AC:
12445
AN:
79166
European-Finnish (FIN)
AF:
0.152
AC:
6982
AN:
45878
Middle Eastern (MID)
AF:
0.0949
AC:
540
AN:
5690
European-Non Finnish (NFE)
AF:
0.139
AC:
149473
AN:
1077734
Other (OTH)
AF:
0.119
AC:
6863
AN:
57860
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.536
Heterozygous variant carriers
0
11023
22046
33070
44093
55116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5422
10844
16266
21688
27110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.101
AC:
15369
AN:
152296
Hom.:
982
Cov.:
34
AF XY:
0.103
AC XY:
7634
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0375
AC:
1561
AN:
41584
American (AMR)
AF:
0.0846
AC:
1294
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0625
AC:
217
AN:
3470
East Asian (EAS)
AF:
0.0629
AC:
325
AN:
5166
South Asian (SAS)
AF:
0.156
AC:
755
AN:
4828
European-Finnish (FIN)
AF:
0.157
AC:
1665
AN:
10618
Middle Eastern (MID)
AF:
0.0986
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
0.136
AC:
9222
AN:
68008
Other (OTH)
AF:
0.110
AC:
233
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
731
1462
2192
2923
3654
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.120
Hom.:
383
Bravo
AF:
0.0918
Asia WGS
AF:
0.111
AC:
388
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jul 05, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 22, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 24, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.62
DANN
Benign
0.80
PhyloP100
-2.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2407083; hg19: chr16-1252118; COSMIC: COSV61986592; COSMIC: COSV61986592; API